Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
GLP-1 for sleep apnea, alcohol use and cancer risk GLP-1s may address conditions well beyond metabolic diseases: Obstructive sleep apnea: Emerging data suggest GLP-1s improve apnea symptoms. Alcohol use disorder: Patients using liraglutide or semaglutide reduced alcohol consumption by nearly two-thirds. Obesity-related cancers: An observational study of 6,000 adults found that GLP-1 receptor agonists halved the risk of obesity-related cancers compared with usual care
However, in contrast to the short and medium-chain acylcarnitines (Table S2), the mean concentration of these 13 long-chain acylcarnitines was significantly lower in the patients (2.67 0.0.87 mol/L) than that in the healthy controls (3.15 0.93 mol/L), and the difference between the two groups generated a significant P-value of 0.0014
These shifts in hydration and mineral balance contribute to headache frequency
In line with our observation, activation of p38 with preconditioning stimuli or over-expression of MKK3/MKK6 has been reported to protect the heart against myocardial I/R injury [5358]
.jpg)